If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
377.50    2.50 (0.67%)
Bid:
374.50
Ask:
376.50
Spread: 2.00 (0.534%)
Market Cap: £1.93b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Directorate Change

29 Jul 2025 16:32

RNS Number : 0414T
Caledonia Investments PLC
29 July 2025
 

 

Caledonia Investments plc

 

Directorate change

 

Caledonia Investments plc ("Caledonia" or the "Company") announces that Lynn Fordham, who has served as a non-executive director of the Company since 1 January 2022, has given notice of her resignation with effect from 31 August 2025.

 

Farah Buckley, who has served on the Board since March 2023, has been appointed as an additional member of the Company's Audit and Risk Committee from 1 August 2025 and will succeed Lynn as its chair on 1 September 2025. The Board will now begin the search for an additional non-executive director.

 

David Stewart, Caledonia's Chair, commented:

 

"On behalf of the Board, I would like to thank Lynn for the considerable contribution that she has made to Caledonia and wish her well for the future.

 

"I am delighted that Farah will join the Audit and Risk Committee and will succeed Lynn as its chair."

 

Enquiries

 

Company contacts

Caledonia Investments plc

+44 20 7802 8080

investorrelations@caledonia.com

 

David Stewart

Chairman

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

 

caledonia@teneo.com

29 July 2025

 

Notes:

 

In accordance with section 430 (2B) of the Companies Act 2006, Caledonia confirms that, other than fees payable to Lynn Fordham as a non-executive director up to the effective date of her resignation, no remuneration or payment has been or will be made in connection with her cessation as a director of the Company.

 

Caledonia Investments plc

 

Caledonia is a FTSE 250 self-managed investment trust company with a long track record of delivering consistent returns and progressive annual dividend payments to shareholders.

 

Our aim is to generate long-term compounding real returns that outperform inflation by 3%-6% over the medium to long term, and the FTSE All-Share index over 10 years.

 

We are a long-term investor and hold investments in both listed and private markets across three pools: Public Companies, Private Capital and Funds. Each has a strategic allocation of capital, investment strategy and target return. The result is a well-balanced diversified portfolio of investments with a global reach.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUUWMUPAGAB
Date   Source Headline
18th Sep 20253:23 pmRNS-RUpdate from QuotedData
4th Sep 20259:31 amRNSNet Asset Value(s)
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20259:31 amRNSAgreement to sell interest in Stonehage Fleming
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20255:01 pmRNSDirector/PDMR Shareholding
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20259:47 amRNSNet Asset Value(s)
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20258:46 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20254:32 pmRNSDirectorate Change
29th Jul 20252:28 pmRNSDirector/PDMR Shareholding
25th Jul 20253:16 pmRNSIrrevocable Share Repurchase Instruction
24th Jul 20257:00 amRNSShare sub-division and total voting rights
23rd Jul 20252:41 pmRNSDirector/PDMR Shareholding
16th Jul 20255:37 pmRNSResult of AGM and update on share sub-division
7th Jul 20257:00 amRNSNet Asset Value(s)
1st Jul 20252:58 pmRNSDirector/PDMR Shareholding
27th Jun 20253:00 pmRNSDirector/PDMR Shareholding
24th Jun 20252:47 pmRNSDirector Declaration
24th Jun 20257:00 amRNSPublic Companies spotlight event
13th Jun 20253:25 pmRNSDirector/PDMR Shareholding
12th Jun 20253:00 pmRNSAnnual report, AGM and proposed share sub-division
5th Jun 20259:30 amRNSNet Asset Value(s)
3rd Jun 20254:05 pmRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTotal Voting Rights
20th May 20257:00 amRNSFinal Results
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSNotice of annual results
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.